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Abstract
BACKGROUND—Floatation-REST (Reduced Environmental Stimulation Therapy), an 
intervention that attenuates exteroceptive sensory input to the nervous system, has recently been 
found to reduce state anxiety across a diverse clinical sample with high levels of anxiety sensitivity 
(AS). To further examine this anxiolytic effect, the present study investigated the affective and 
physiological changes induced by Floatation-REST and assessed whether individuals with high 
AS experienced any alterations in their awareness for interoceptive sensation while immersed in an 
environment lacking exteroceptive sensation.
METHODS—Using a within-subject crossover design, 31 participants with high AS were 
randomly assigned to undergo a 90-minute session of Floatation-REST or an exteroceptive 
comparison condition. Measures of self-reported affect and interoceptive awareness were collected 
before and after each session, and blood pressure was measured during each session.
RESULTS—Relative to the comparison condition, Floatation-REST generated a significant 
anxiolytic effect characterized by reductions in state anxiety and muscle tension and increases in 
feelings of relaxation and serenity (p < .001 for all variables). Significant blood pressure 
reductions were evident throughout the float session and reached the lowest point during the 
diastole phase (average reduction >12 mm Hg). The float environment also significantly enhanced 
awareness and attention for cardiorespiratory sensations.
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CONCLUSIONS—Floatation-REST induced a state of relaxation and heightened interoceptive 
awareness in a clinical sample with high AS. The paradoxical nature of the anxiolytic effect in this 
sample is discussed in relation to Wolpe’s theory of reciprocal inhibition and the regulation of 
distress via sustained attention to present moment visceral sensations such as the breath.
Keywords
Anxiety; Blood pressure; Floatation-REST; Floating; Interoception; Mindfulness; Novel 
intervention; Relaxation response
Anxiety sensitivity (AS) refers to one’s fear of experiencing anxiety-related symptoms and 
sensations, especially those arising from within the body (1). Individuals with high AS often 
believe that these sensations can lead to adverse consequences, such as death, insanity, or 
social rejection. Such catastrophic misinterpretations make AS an anxiety amplifier; 
individuals with high AS are easily alarmed by anxiety-related sensations, and exposure to 
such sensations often further intensifies their anxiety (1). For this reason, AS has been 
referred to as a fundamental fear distinct from derivative ones such that the fear of anxiety 
can provide a motive for avoiding any stimulus likely to incite anxious symptoms (2). 
Consequently, most cases of chronic anxiety—including panic disorder, agoraphobia, 
generalized anxiety disorder, social anxiety disorder, and posttraumatic stress disorder—also 
feature high levels of AS, making AS a core construct underlying the initiation and 
maintenance of pathological anxiety (3,4).
Recent evidence suggests that reducing AS may be important for the prevention and 
treatment of anxiety across diagnostic categories. Prospective studies have shown that AS is 
a strong predictor for the onset of mood and anxiety disorders and the development of 
spontaneous panic attacks (1,5,6), whereas longitudinal studies have shown that individuals 
with high AS have a propensity for greater chronicity of illness and a higher likelihood of 
experiencing future anxiety symptoms (3,7,8). Controlled studies have shown significant 
reductions in AS following successful treatment with psychotherapy (9) or pharmacotherapy 
(10), and several transdiagnostic treatments have been developed to specifically target AS 
using different forms of interoceptive exposure (11–14). Taken together, this evidence 
supports the notion that AS is a fundamental driver of anxiety, and treatments that target AS 
have the potential of helping patients overcome anxiety regardless of their specific anxiety 
diagnosis (11).
Our laboratory has recently started to investigate a novel intervention for anxiety that may be 
beneficial for patients with high levels of AS. Referred to as Floatation-REST (Reduced 
Environmental Stimulation Therapy), the procedure entails floating supine in a shallow pool 
of water saturated with magnesium sulfate (Epsom salt). The float experience is calibrated 
so that sensory signals from visual, auditory, olfactory, gustatory, thermal, tactile, vestibular, 
gravitational, and proprioceptive channels are minimized, as are most movement and speech. 
Prior research investigating Floatation-REST has mostly focused on healthy populations, 
with the most consistent finding being decreases in indices of stress and increases in 
relaxation as measured from before to after the float session (15,16). Thus far, there has been 
only one controlled study in participants with clinical anxiety, and the findings showed 
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significant reductions in self-reported symptoms of generalized anxiety following 12 
sessions of Floatation-REST that was maintained at 6-month follow-up (17). In a recently 
completed open-label study (18), we recruited a sample of 50 anxious and depressed 
participants spanning a range of different anxiety and stress-related disorders (including 
posttraumatic stress disorder, generalized anxiety disorder, social anxiety disorder, panic 
disorder, and agoraphobia). Participants underwent a single 1-hour session of Floatation-
REST, and overall the procedure was well tolerated, with no major safety concerns or 
adverse events. Regardless of diagnosis, the float experience induced a strong short-term 
reduction in state anxiety and a substantial improvement in mood. A subgroup analysis 
revealed that the participants with the highest AS experienced the greatest reduction in 
anxiety. To follow up on these findings, the current investigation recruited participants with 
high AS from the initial open-label study to complete a more intensive protocol that 
included both a comparison condition and concurrent measurement of blood pressure (BP), a 
key index of the relaxation response (19). Since other transdiagnostic treatments targeting 
AS feature manipulations that enhance exposure to interoceptive sensations (11–14), we 
were also interested in exploring whether the float environment altered interoceptive 
awareness, a construct that surprisingly has not been formally investigated in prior studies of 
Floatation-REST despite initial anecdotal reports of enhanced cardiac awareness (20) as well 
as initial experimental evidence of enhanced cardiac control (21). We hypothesized that by 
removing exteroceptive sensation, Floatation-REST would enhance awareness for 
interoceptive sensation.
METHODS AND MATERIALS
All study procedures were approved by the Western Institutional Review Board, and all 
participants provided written informed consent prior to participation. The trial was registered 
on ClinicalTrials.gov (https://clinicaltrials.gov/show/NCT03051074), and this study is part 
of a larger project examining the subjective, physiological, and neural effects of Floatation-
REST.
Participant Recruitment and Randomization
The current protocol used a within-subject crossover design. Participants who met specific 
inclusion and exclusion criteria (see Supplemental Table S1 and Supplement) were 
randomly assigned (Supplemental Figure S1) to complete either a 90-minute session of 
Floatation-REST (referred to as the float condition) or a 90-minute session of an 
exteroceptive comparator (referred to as the film condition) that entailed watching a nature 
documentary from the BBC Planet Earth series (22). After completion of one condition, 
participants crossed over to the other condition approximately 1 week later (average time 
between conditions was 8 days), with both conditions scheduled to occur at the same time of 
day for each participant. The randomization sequence was predetermined using a 1:1 
allocation ratio, and the study used an open-label design with no blinding or concealed 
allocation. More details about the Floatation-REST intervention and the exteroceptive 
comparator can be found in the Supplement.
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Measures
All self-report measurements were administered electronically to participants via an 
electronic tablet (Apple iPad). Survey measures were obtained using REDCap (Research 
Electronic Data Capture; www.project-redcap.org), a secure web-based application for 
electronic collection and management of research and clinical trial data. Three different 
types of self-report measures were administered (see Supplement for specific details about 
each measure): baseline measures, before and after session measures, and interoceptive 
measures. The baseline measures assessed each participant’s current symptoms and level of 
functioning during the time period of the study. The before and after measures were 
collected at two time points, approximately 30 minutes before and after each float or film 
session, to assess state-related changes in anxiety [primary outcome measure: change score 
on Spielberger State Anxiety Inventory (23)] and relaxation. At each time point, participants 
rated how they felt “right now, in the present moment.” In contrast, the interoceptive 
measures were aimed at gathering retrospective data about how participants felt during the 
actual float or film experience. Participants also completed a short debriefing interview with 
the experimenter at the end of the float condition to gather more qualitative information 
about the float experience and assess for adverse reactions. Finally, BP was measured at 10-
minute intervals during each float or film session using a wireless and waterproof setup (see 
Supplement).
Statistical Analysis
Change scores were computed for all before- and after-session measures, and most analyses 
were focused on between-session contrasts of the change scores. To be consistent with the 
range of scores (0–100) on the visual analog scale, each participant’s raw score for state 
anxiety, serenity, and interoceptive attention was first converted into standardized POMP 
units [representing the percent of maximum possible for each measure ranging from 0 to 
100% (24)]. All measures were analyzed by linear mixed-effects models (LMMs). The 
LMM included fixed effects of session (float vs. film), time (after vs. before for the before 
and after measures; 0, 5, 10, 15, 25, 35, 45, 55, 65, and 75 minutes for the BP measures), 
and session-by-time interactions; a random intercept and/or a random time-slope were 
considered to account for participant-specific random effects. As all the interoceptive 
measures were focused on a single period of time (either during the float session or during 
the film), the LMM applied to these measures included only fixed effects of session. We 
focused on the session-by-time interactions for all before-session and after-session measures 
and BP measures, and between-session differences for all interoceptive measures. The p 
values were corrected for multiple comparisons by controlling false discovery rate at a 5% 
level. For each outcome measure, we also explored the potential effects of different 
covariates (age; sex; medication status; randomization order; and baseline severity of 
psychiatric symptoms based on scores from the Overall Anxiety Severity and Impairment 
Scale, Patient Health Questionnaire nine-item depression scale, and Sheehan Disability 
Scale), and we report covariates chosen by the Bayesian information criterion at the end of 
the Supplement. All analyses were performed with RStudio version 1.0.136 (R Foundation 
for Statistical Computing, Vienna, Austria) with R version 3.3.2, using the R packages lme4 
(version 1.1–14) for LMM and lmerTest (version 2.0–33) for calculation of degrees of 
freedom and p values based on the Kenward-Roger method.
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RESULTS
Sample Characteristics
There were 31 participants who met inclusion and exclusion criteria (Supplemental Table 
S1) and underwent Floatation-REST and the exteroceptive comparison condition. All 
participants met criteria for one or more anxiety disorders; Table 1 provides additional 
details about subject demographics and baseline level of functioning. The sample spanned 
the spectrum of different anxiety and stress-related disorders, with a mix of comorbidities, 
including generalized anxiety disorder (n = 17), social anxiety disorder (n = 11), panic 
disorder (n = 9), agoraphobia (n = 8), and posttraumatic stress disorder (n = 11). Nearly 
every participant also had comorbid unipolar major depressive disorder (n = 29). Two thirds 
of the participants (n = 21) were stably medicated (for 6 weeks or longer) on one or more 
psychotropic medications, including selective serotonin reuptake inhibitors, serotonin and 
norepinephrine reuptake inhibitors, norepinephrine and dopamine reuptake inhibitors, 
benzodiazepines, opiates, and tricyclic antidepressants. At baseline (Table 1), most 
participants were acutely anxious and depressed, with average scores well above the clinical 
range of severity (Overall Anxiety Severity and Impairment Scale score = 10.0; Patient 
Health Questionnaire nine-item depression scale score = 11.6). Participants also presented 
with high levels of AS (average Anxiety Sensitivity Index-3 total score = 28.1) as well as 
marked impairment in social and occupational functioning (average total disability score on 
the Sheehan Disability Scale = 14.7).
Safety and Tolerability of Interventions
There were no serious adverse events or major safety concerns arising during or after 
Floatation-REST. Most participants chose to float for the entire 90-minute duration, with the 
exception of 5 participants who exited the pool shortly after the music signaling the end of 
the float session started playing (approximately 85 minutes into the float). All participants 
completed the 90-minute film.
Overall, participants rated both conditions as being pleasant on a 100-point bipolar valence 
scale ranging from −50 (extremely unpleasant) to −50 (extremely pleasant). The average 
valence rating for the float condition was 32.1 (SD 10.8), and the average valence rating for 
the film condition was 21.6 (SD 18.3), with participants rating the float as significantly more 
pleasant than the film (t30 = 2.77, p < .01).
Measures Before and After Floatation-REST
All measures before and after Floatation-REST (Figure 1) showed a significant session-by-
time interaction (p < .001). More specifically, after the float condition, participants reported 
substantial reduction in state anxiety and muscle tension and substantial increases in serenity 
and relaxation. In comparison, after the film condition, participants reported a similar 
direction of change on these measures, but the magnitude of change was significantly 
smaller than the float condition (Figure 1). Further exploration into the muscle tension 
changes revealed that the reduction in muscle tension while floating was felt most 
prominently throughout the upper and lower back (Figure 2), although some residual tension 
remained in the neck. In contrast, the film condition had little effect on muscle tension and 
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seemed to elicit an increase in the number of participants reporting tension in regions of the 
upper and lower back and gluteus muscles (Figure 2).
Blood Pressure
At baseline, just before beginning the float or film, participants started at a similar level of 
BP (Figure 3). The float condition, but not the film, induced a reduction in both systolic BP 
(Figure 3A) and diastolic BP (Figure 3B). The session-by-time interaction was significant 
for diastolic BP (p < .001) but only marginally for systolic BP (p = 0.13). Nevertheless, there 
was still a highly significant main effect of session for systolic BP (p < .001). The drop in 
diastolic BP during the float session was more than twice as large as the drop in systolic BP 
and occurred more rapidly, evident even at the first measurement taken 5 minutes into the 
float session (Figure 3B). For both systolic and diastolic measures, BP reductions were most 
prominent over the first 15 minutes and then tended to plateau throughout the remainder of 
the float session. The average change from baseline, as calculated across the plateau phase 
of the float session (15–75 minutes), showed an overall reduction in systolic BP of 5.3 mm 
Hg and an overall reduction in diastolic BP of 12.8 mm Hg. The 95% confidence interval 
was computed at each time point that BP was measured (Figure 3), revealing a large spread 
between values obtained during the float versus film conditions for diastolic BP (Figure 3B). 
Notably, diastolic BP was reduced in every participant during the float condition. In 
comparison, the film condition did not significantly alter BP, with an average drop in 
systolic of 0.7 mm Hg and an average drop in diastolic of 1.4 mm Hg.
Interoceptive Measures
During the float session, participants reported a significant increase (p < .001) in the 
intensity of cardiorespiratory sensations compared with the film condition (Figure 4A). 
Likewise, participants also reported a significant increase (p < .001) in attention to 
cardiorespiratory sensations during the float session (Figure 4B) and reported that these 
sensations felt significantly (p < .05) more pleasant while floating than during the film 
(Figure 4C). Interestingly, the significant increases in interoceptive intensity, attention, and 
positive valence during the float were specific to cardiorespiratory sensations (i.e., breath 
and heartbeat) but not gastrointestinal sensations from the stomach and digestive system. 
Whereas most participants did not feel their heartbeat during the film condition, many 
reported a clear expansion in where the heartbeat sensation was experienced during the float 
session, including the chest, ears, eyes, and top of the scalp (Figure 5). On a modified state 
version of the Multidimensional Assessment of Interoceptive Awareness (25), floating 
significantly enhanced (p < .001) attention regulation (ability to sustain attention on body 
sensations) and self-regulation (ability to regulate distress by attending to body sensations 
such as the breath) compared with the film (Figure 6). This pattern of improved self-
regulation and heightened interoceptive awareness and attention for cardiorespiratory 
sensations was also a common theme conveyed by participants during the postfloat 
debriefing (see the Debriefing Transcriptions in the Supplement).
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DISCUSSION
There were two main findings in this study: 1) a group of clinically anxious and depressed 
individuals with high levels of AS experienced a robust relaxation response during and after 
Floatation-REST that was decisively anxiolytic in nature (18); and 2) the float environment 
enhanced interoceptive awareness and attention to cardiorespiratory sensations. For both 
findings, the effects during Floatation-REST were significantly greater than during the 
exteroceptive comparison condition. Each of the main findings is discussed in greater detail 
below.
First, the float environment elicited a relaxation response that was evident both 
physiologically (via reduced BP) and psychologically (via reduced levels of state anxiety 
and muscle tension and increased levels of relaxation and serenity). Notably, the relaxation 
response was significantly larger during Floatation-REST than during the comparison 
condition, which involved an activity that many people use to help them relax—watching 
television (in this case a low-arousal pleasant nature documentary from the BBC Planet 
Earth series). As this was every participant’s second float session, the significant self-report 
changes represent a replication of the anxiolytic effect previously observed during the first 
float session (18), an effect that was similarly characterized by reductions in state anxiety 
and muscle tension and increases in relaxation and serenity. Interestingly, the magnitude of 
state anxiety reduction found in the current study was commensurate with the magnitude of 
reduction found in the initial float study (with both studies showing an average reduction of 
approximately 14 points when calculating the before-session to after-session change using 
the raw total score on the Spielberger State Anxiety Inventory) (18).
This investigation was the first study to measure BP changes during an actual session of 
Floatation-REST. Although the findings await further replication, they are consistent with 
previous research showing longer-term reductions in BP following the completion of 
multiple float sessions (26–29). Future work will need to closely track the temporal course 
of these BP fluctuations to determine how long the effects last after a float session is over. 
During the float session, the reduction in BP occurred over the first 15 minutes, eventually 
reaching a plateau that persisted for the remainder of the session. On average, systolic BP 
reduced by approximately 5 mm Hg, whereas diastolic BP showed a more pronounced 
reduction of approximately 13 mm Hg that occurred quite rapidly (often within the first 5 
minutes of the float session). Potential factors contributing to the noted reductions in BP are 
discussed in the Supplement.
The mechanism of action underlying the physiological and psychological changes elicited 
by Floatation-REST is currently unknown but is likely multifaceted. For example, the 
reduction in state anxiety is likely a by-product of the float environment, which minimizes 
exposure to most external triggers of stress and anxiety, providing a chronically anxious and 
hypervigilant nervous system with a rare respite from the daily barrage of external triggers 
that it has been sensitized to over the years. The reduction in BP could be related to 
peripheral vasodilation caused by immersion in the warm water, possibly mediated through 
relaxation of vascular smooth muscles (see Supplement). Likewise, relaxation of skeletal 
muscles and the concomitant reduction in both muscle tension and movement is likely 
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related to the water density (calibrated to a specific gravity of approximately 1.26 to suspend 
the body in a state of neutral buoyancy, where approximately half of the body is floating 
above the surface of the water and the other half is submerged under the water). The 
reduction in muscle tension, especially in the upper and lower back, was one of the more 
prominent effects found in this study and could play an important role in the positive 
benefits derived from Floatation-REST. Consistent with this notion, a recent investigation 
found that musculoskeletal pain was the most commonly reported somatic symptom across 
all types of depressive and anxiety disorders (30), and it remains possible that Floatation-
REST is uniquely suited to address these somatic issues.
Second, with regard to interoception, the data suggest that being immersed in an 
environment lacking exteroceptive sensation does seem to alter the experience of 
interoceptive sensation, leading present moment visceral sensations to emerge at the center 
of conscious experience during Floatation-REST. This floatation-induced internal sensory 
enhancement appeared to show some degree of specificity for cardiorespiratory visceral 
sensations, whereas gastrointestinal sensations from the stomach and digestive system were 
not enhanced. More specifically, the float environment seemed to reflexively increase the 
intensity for, and attention to, interoceptive sensations related to the breath and heartbeat 
(Figure 4). These findings are notable, especially since most individuals, including 
experienced meditators, show relatively poor interoceptive awareness for cardiac sensation 
under resting conditions (31,32). Although individuals with high AS do tend to have 
heightened interoceptive awareness (33,34), it is worth emphasizing that the aforementioned 
enhancement effects cannot be fully attributed to a global increase in interoceptive 
awareness in this sample, as these same participants did not report any enhancement during 
the film condition. Given the heightened AS in this sample and the heightened awareness of 
cardiorespiratory sensations, it is notable that these sensations were rated as pleasant (Figure 
4C), a finding that surprised a number of participants who were used to associating 
cardiorespiratory sensations with the feeling of anxiety (see Debriefing Transcriptions in the 
Supplement).
The current results present a paradox, as one might expect individuals with high AS to find 
the heightened experience of interoceptive sensations to be anxiety inducing (rather than 
reducing). Indeed, years of conditioning have linked interoceptive sensations to the 
experience of anxiety (35,36), and in the case of AS, this conditioning process can quickly 
go awry, triggering a pervasive pattern of avoidance that often culminates in one or more of 
the anxiety disorders. This brings forth the question as to why patients with high levels of 
AS would find serenity in an environment that enhances awareness for visceral systems 
previously linked to anxiety. Perhaps one answer to this paradoxical question is encapsulated 
by Wolpe’s seminal theory on reciprocal inhibition, premised on the notion that it is 
physiologically implausible for the nervous system to be in a state of anxious arousal and a 
state of relaxation at the same time (37). Wolpe’s theory can be summarized as follows: “If a 
response antagonistic to anxiety can be made to occur in the presence of anxiety-evoking 
stimuli so that it is accompanied by a complete or partial suppression of the anxiety 
responses, the bond between these stimuli and the anxiety responses will be weakened” (37, 
p. 71). Building on this theory, the findings presented here suggest that Floatation-REST 
may shift the nervous system into a physiologically quiescent state, one that is antagonistic 
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to anxiety. At the same time, the float environment appears to enhance awareness for 
visceral systems intimately linked with the experience of anxiety. The emerging clinical 
effect, however, appears to be one of anxiety reduction, evident in individuals with a range 
of different anxiety and stress-related disorders who all share the common feature of AS. In 
cases of high AS, it is possible that part of the anxiolytic effect induced by Floatation-REST 
stems from reciprocal inhibition, whereby the bond between visceral sensations and anxiety 
is weakened, and a competing association is formed, one that links the experience of visceral 
sensations with a state of relaxation instead of anxiety. Thus, if Wolpe’s theory holds true, 
Floatation-REST may not only lead to short-term reductions in anxiety, but also, over time 
and with repeated exposure, the practice may lead to long-term reductions in AS.
Limitations and Future Directions
Although this study used a within-subject randomized controlled design, replication in a 
larger sample, with longitudinal follow-up, and a more active comparator will be critical 
next steps for assessing the anxiolytic efficacy of Floatation-REST. Given that all 
participants completed an initial float session before this study, the current results may be 
affected by demand characteristics and biased responses stemming from the first float 
session. The film comparator used in the current study employed exteroceptive audiovisual 
stimulation while participants sat upright in a chair, features that likely magnified the 
differences between conditions on measures of interoceptive awareness and muscle tension. 
In addition, the current study was limited by its focus on acute effects following a single 
float session, and it will be imperative to explore the cumulative effects of multiple float 
sessions in anxious populations to determine whether there is evidence for sustained long-
term benefit (17) or signs of adverse effects. In addition, very little is known about how long 
the acute effects persist after a float is over, and a better understanding for the duration of the 
acute effects will help determine other factors, such as the optimal “dose” and frequency of 
floating. Beyond BP, it will be important to also explore other physiological (e.g., heart rate 
variability and respiration) and neural (e.g., electroencephalography and/or functional 
magnetic resonance imaging) parameters to have a more complete understanding of how 
Floatation-REST affects the nervous system. Likewise, the interoceptive measures in the 
current study were derived via self-report, and future studies should employ behavioral 
paradigms for more objectively assessing interoceptive accuracy.
The enhancement of awareness and attention for cardio-respiratory sensations during 
Floatation-REST occurred without explicit mindfulness instruction or training. The 
seemingly reflexive nature of the interoceptive enhancement provided by the float 
environment may have important therapeutic implications, as the cultivation of present 
moment awareness via sustained attention to the breath is a fundamental feature of many 
meditative traditions (38,39). Although the practice of meditation appears to help reduce 
anxiety (40), the effects are often of a small to medium size (41,42), with many acutely 
anxious patients finding it difficult to sustain their focus on present moment sensations (43). 
In this light, the float environment may help anxious individuals anchor their attention onto 
internal sensations such as the breath, both by extreme filtering of all external sensory 
distractors and stressors and by enhancing the feeling of the heartbeat and the breath. The 
data further suggest that Floatation-REST may help bolster self-regulation and the reduction 
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of anxiety and distress through sustained attentional focus on present moment body 
sensations (Figure 6), highlighting the conducive nature of the float environment for 
facilitating the learning of core skills involved in the training of mindfulness (44). Future 
research should further explore these preliminary findings to determine whether Floatation-
REST facilitates the practice of mindfulness and whether the combination of floating with 
specific mindfulness instructions can lead to even greater anxiolytic effects.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Anxiolytic effect of floatation therapy. **p < .001. Error bars represent SEM. PANAS-X, 
Positive and Negative Affect Schedule–Expanded Form; POMP, percent of maximum 
possible; STAI, State-Trait Anxiety Inventory; VAS, visual analog scale.
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Figure 2. 
Muscle tension tracings. Participants traced any regions where they felt muscle tension. The 
color scale is filtered to show areas of overlap ranging from 3 to 16 participants.
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Figure 3. 
Average (A) systolic and (B) diastolic blood pressure over time in the float and film 
conditions. Time 0 is baseline. Shaded regions represent the pointwise 95% confidence 
interval.
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Figure 4. 
Interoception ratings during the float (solid bars) and film (hatched bars) conditions. Error 
bars represent SEM. Ratings of (A) intensity, (B) attention, and (C) valence are shown for 
three different visceral systems. *p < .05; **p < .001. POMP, percent of maximum possible.
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Figure 5. 
Heartbeat sensation tracings. Participants traced any regions where they felt their heartbeat. 
The color scale is filtered to show areas of overlap ranging from 3 to 16 participants.
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Figure 6. 
Average score (range, 0–5) on the attention regulation and self-regulation subscales of the 
Multidimensional Assessment of Interoceptive Awareness. Error bars represent SEM. **p 
< .001.
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Table 1
Participant Demographics and Baseline Functioning
Variable All Participants
Participants First Randomized to 
Film
Participants First Randomized to 
Float
Sample Size 31 16 15
Age, Years 39.1 (11.1) 38.2 (11.7) 39.9 (11.0)
Sex, Male/Female 12/19 4/12 8/7
Medicated Subjects 21 9 12
Anxiety Sensitivity (ASI-3) 28.1 (12.3) [23.6, 32.6] 29.4 (14.2) [21.5, 37.3] 26.9 (10.6) [21.2, 32.5]
Anxiety Severity (OASIS) 10.0 (3.8) [8.6, 11.4] 9.5 (4.3) [7.2, 11.9] 10.4 (3.4) [8.6, 12.3]
Depression Severity (PHQ-9) 11.6 (5.5) [9.6, 13.6] 9.9 (5.8) [6.7, 13.2] 13.1 (4.8) [10.5, 15.7]
Level of Disability (SDS) 14.7 (8.0) [11.8, 17.6] 13.2 (8.1) [8.7, 17.7] 16.1 (7.8) [12.0, 20.3]
The total or average scores are presented for each metric. Numbers inside parentheses represent the standard deviation, and numbers inside brackets 
represent the 95% confidence interval.
ASI-3, Anxiety Sensitivity Index-3; OASIS, Overall Anxiety Severity and Impairment Scale; PHQ-9, Patient Health Questionnaire nine-item 
depression scale; SDS, Sheehan Disability Scale.
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